In this meta-analysis, addition of vasopressin to catecholamine vasopressors was associated with a lower risk for atrial fibrillation compared with catecholamine monotherapy. However, while there was decreased mortality with vasopressin plus catecholamines, this difference was not seen when restricting analysis to studies with a low risk for bias.
Endometrial cancer survivors have an elevated risk of various adverse long-term cardiovascular outcomes.
Andexxa, a recombinant modified human Factor Xa (FXa) protein, was approved under the FDA's Accelerated Approval pathway.
Peripheral artery disease with a borderline ankle-branchial index appears not to increase the risk for atrial fibrillation.
Anxiety may increase the risk for ischemic stroke and intracranial hemorrhage in patients with atrial fibrillation.
Regular intake of coffee and tea seems safe and may be beneficial, although energy drinks may increase risk for arrhythmia.
Possible correlation also seen for nut consumption with reduced risk for heart failure, myocardial infarction, and abdominal aortic aneurysm.
Complete reversal was seen within 4 hours in the majority of patients, as measured by ecarin clotting time (ECT 82%) or diluted thrombin time (dTT 99%). In addition, there was a low late of thrombotic events and no new safety events were reported.
Increased right atrial and pulmonary wedge pressures and increased thyroid disease prevalence were associated with atrial arrhythmia development in idiopathic or systemic sclerosis-related pulmonary arterial hypertension.
For patients post coronary artery bypass graft surgery, new-onset postoperative atrial fibrillation is associated with lower long-term thromboembolic risk than that seen among patients with nonvalvular atrial fibrillation.
Risk up with use of non-selective NSAIDs and combined use of selective, non-selective NSAIDs.
Depression and use of an antidepressant are associated with atrial fibrillation.
Compared with patients not taking digoxin, patients with a serum digoxin concentration of ≥1.2 ng/mL had a 56% increased hazard of mortality.
A meta-analysis sought to determine the effect of influenza vaccination on cardiac-related mortality in patients with heart failure.
African-Americans are at an increased risk of developing an ischemic stroke before or after atrial fibrillation diagnosis compared with whites.
Using digital adherence devices to improve medication adherence in patients with atrial fibrillation may reduce the rate of ischemic strokes.
Anticoagulants are associated with increased risk for ischemic stroke and hemorrhage in older patients with chronic kidney disease and a new diagnosis of atrial fibrillation.
Catheter ablation of atrial fibrillation in heart failure reduces mortality and hospitalization: The CASTLE-AF trialFebruary 20, 2018
Compared with medical therapy alone, catheter ablation of atrial fibrillation in patients with heart failure reduced the risk for all-cause mortality and hospitalization.
Patients with persistent atrial fibrillation who received targeted therapy saw improvements in sinus rhythm as well as reductions in blood pressure, cholesterol, and weight.
A 45-year-old man presents to the emergency department with some mental confusion and near syncope.
Surgical left atrial appendage occlusion is associated with a lower risk for thromboembolism-related hospital readmission in older patients with atrial fibrillation who undergo cardiac surgery.
A 35-year-old pregnant woman presents to the emergency department with progressive dyspnea and palpitations that have worsened during the last 3 weeks.
Migraine was associated with elevated risks of myocardial infarction, stroke (ischemic and hemorrhagic), venous thromboembolism, and atrial fibrillation or flutter.
Catheter ablation was associated with a significant reduction in a composite end point of death from any cause or hospitalization for worsening heart failure in patients with atrial fibrillation.
The next best diagnostic step in the workup of acute ischemic stroke in context of updated 2018 guidelines is discussed.
Patients with atrial fibrillation have a higher risk for ischemic stroke compared with patients with atrial flutter.
Uninterrupted and minimally interrupted apixaban are associated with low rates of thromboembolic events in patients undergoing catheter ablation for nonvalvular afib.
Current evidence is inadequate to assess benefits and harms of ECG screening for atrial fibrillation.
Cost-effective DOACs like apixaban prevent strokes better than warfarin in patients with atrial fibrillation.
Bleeding Risk, Stroke Outcomes With Edoxaban vs Enoxaparin-Warfarin for Cardioversion of Atrial FibrillationDecember 15, 2017
In patients with atrial fibrillation at high risk for stroke, edoxaban is associated with lower rates of cardiovascular death events.
The Cardiology Advisor Articles
- Oral Anticoagulant Effective in Recurrent VTE Prevention in Cancer Patients
- Updated Blood Pressure Guidelines Identify Children With Previously Underestimated Risk
- Egg-and-Banana Sign Has High Specificity for Pulmonary Hypertension Diagnosis
- Hyoscyamine Helps in Afib With Slow Ventricular Response
- AHA: Annual OB/GYN Appointment Can Benefit Women's Heart Health
- Tenecteplase Appears Superior to Alteplase After Ischemic Stroke
- Oxygen Therapy in Acute MI Not Associated With Clinical Benefit
- Hyoscyamine Helps in Afib With Slow Ventricular Response
- Transforming Congenital Heart Disease Outcomes With 3D Printing
- Deep Venous Thrombosis Ultrasound Protocol Recommendations
- International Liaison Committee on Resuscitation Identifies CPR Knowledge Gaps
- Coronary Heart Disease Mortality Often Attributed to Sudden Arrhythmic Death
- Doctors May Avoid Performing PCI Due to Public Reporting
- Best Practices Developed for Use of EHR to Enhance Patient Care
- FDA Approves Epoetin Alfa Biosimilar Retacrit